We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 37 Manufacturers, Suppliers and Companies | IPROS GMS

Last Updated： Aggregation Period:Feb 18, 2026～Mar 17, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Feb 18, 2026～Mar 17, 2026
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. Panorama Data Insights Ltd. Tokyo//Testing, Analysis and Measurement
  4. 4 大塚化学 Tokyo//Chemical
  5. 5 立山化成 Toyama//Manufacturing and processing contract
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Feb 18, 2026～Mar 17, 2026
This ranking is based on the number of page views on our site.

  1. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  2. Pharmaceutical CDMO services 大塚化学
  3. Tateyama Kasei Co., Ltd. Kyushu Factory 立山化成
  4. 4 Development of various types of medium-sized molecule (nucleic acid, peptide) pharmaceuticals (processes, analytical methods, etc.)
  5. 4 [Research Material] The Global Market for Acetylsalicylic Acid マーケットリサーチセンター

medicine Product List

31～60 item / All 611 items

Displayed results
Tohoku University Technology: Organ Fibrosis Inhibitor: T13-204

Tohoku University Technology: Organ Fibrosis Inhibitor: T13-204

Confirmed the effects of fibrosis and inflammation improvement in a kidney fibrosis model mouse!

When the kidneys are damaged for some reason, it is known that inflammation and fibrosis can occur. As symptoms progress, kidney failure can develop, necessitating regular dialysis. Dialysis places a significant burden on patients, and there is a desire for the development of therapeutic drugs that can delay the initiation of dialysis. The inventors have discovered compounds with anti-inflammatory and anti-fibrotic effects. The group of compounds in this invention is expected to be utilized as fibrosis inhibitors.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tohoku University Technology: 1,3-Dioxolane derivative, D-532: T18-094

Tohoku University Technology: 1,3-Dioxolane derivative, D-532: T18-094

Renal functions and tissues in diabetic nephropaty models is improved through D-532 oral administration.

The number of dialysis patients continues to increase, and it is known that applox. 40% of the patients requiring dialysis in Japan were ordinally those with diabetic nephropathy (DN). The treatment for DN is often symptomatic by controling blood sugar and blood pressure, and to date, no effective therapeutic agent for curative treatment has been developed.　 　This invention discloses a 1, 3-dioxolane compounds D-532 and the derivertives thereof, which inhibits the function of the glucose-responsive transcription factor ChREBP (Carbohydrate responsive element binding protein), for DN treatment. 　D-532 was found by ordinally constructed high-throughput screening based on ChREBP reporter assay with applox. 7,000 of compound library in Tohoku University (Fig.1). Synthesized analogs and isomers thereof were also tested and showed inhibitory effect against ChREBP function, although D-532 showed the highest activity (Data not shown). 　The expression of ChREBP target genes were suppressed by D-532 administration for DN animal model (Fig.2). Urinary albumin excretion and blood creatinine were also improved in DN animals with D-532 (Fig.3). Further, the disappearance of foot process in glomerulus, which is often observed in DN kidney, was suppressed (Data not shown), suggesting that D-532 may act directly to renal tissue and show the effects above.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tohoku Univ. Technology : Drugs for Stress urinary incontinence: T16-194

Tohoku Univ. Technology : Drugs for Stress urinary incontinence: T16-194

Novel mechanisms targeting luteinizing hormone

Stress urinary incontinence (SUI) is a disorder that affects young and old people and significantly reduces their quality of life. It has been thought to be caused by a decrease in estrogen, but estrogen replacement therapy has not been sufficiently effective, and there is currently no effective oral treatment that is the first choice, so the development of new therapeutic agents is expected. Because of the poor prognosis of SUI in patients with high serum luteinizing hormone (LH) levels before radical prostatectomy, the inventors considered LH to play an important role in urinary function.　 　To test this hypothesis, they found that the gonadotropin-releasing hormone GnRH antagonists degarellirex or cetrorellix suppressed LH and improved urethral pressure in model rats that reproduced the menopausal state by removing the bilateral ovaries and had elevated LH. The results showed that there is a relationship between SUI and elevated LH, and that GnRH antagonists that suppress LH may be novel therapeutic agents.　

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tohoku Univ. Technology ： The Treatment and Prevention of Inflammatory Bowel Disease : T23-033

Tohoku Univ. Technology ： The Treatment and Prevention of Inflammatory Bowel Disease : T23-033

Anti-inflammatory effect by xCT inhibition or Glutamine synthetase inhibition

　The limited number of drugs available for the treatment of inflammatory bowel disease(IBD) and their severe side effects, including immunosuppression, have led to calls for research into drugs without side effects.　 　The inventors focused on the role of xCT, a cystine/glutamate antiporter, in IBD. Their research suggests that xCT inhibitors or glutamine synthetase inhibitors may be therapeutic/preventive agents for inflammatory diseases. [RESULTS] ・Mice with intestinal epithelium-specific xCT deficiency showed anti-inflammatory effects on dextran sulfate sodium(DSS) colitis(Fig.1). ・Glutamine synthetase inhibitor (MSO：Methionine sulfoximine) showed anti-inflammatory effects on DSS colitis(Fig.2).

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tohoku Univ. Technology：A novel therapeutic target Vasohibin-2: T18-447_T12-072

Tohoku Univ. Technology：A novel therapeutic target Vasohibin-2: T18-447_T12-072

For the treatment of refractory cancers including pancreatic cancer

Vasohibin-2 (referred to as VASH2) knockdown significantly reduced metastasis of pancreatic cancer cells (Fig. 1) and prolonged survival period after orthotopic transplantation (Fig.2). The mechanisms of action are;　 (1)VASH2 knockdown reduces cancer cell invasion through suppressing of tubulin carboxypeptidase activity within the cell. (2) VASH2 secreted by cancer cells stimulates tumor angiogenesis, so when VASH2 was knocked down, tumor angiogenesis was prevented. (3) VASH2 regulates the production of inflammatory chemokines and cytokines in cancer cells, which in turn, accelerates the recruitment of MDSC and TAM and prevents the infiltration of cytotoxic T lymphocytes. The inhibition of VASH2 eliminates immune suppression in pancreatic cancer.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tohoku Univ. Technology：Lubiprostone, a constipation drug, has a kidney protective effect：T25-005

Tohoku Univ. Technology：Lubiprostone, a constipation drug, has a kidney protective effect：T25-005

Improvement of Intestinal Microbiota Improves Mitochondrial Function

Chronic kidney disease (CKD) is a major global health issue without any drugs that improve kidney function. Previous mouse experiments showed that lubiprostone, a constipation drug, reduces uremic toxin accumulation by improving the intestinal environment altered by kidney decline, thus inhibiting kidney damage progression 1. A phase II clinical trial was conducted to test lubiprostone's effects on kidney function in patients. Results revealed dose-dependent suppression of kidney function decline (eGFR) in lubiprostone-treated patients compared to placebo. Further analysis showed lubiprostone improves kidney mitochondrial function by modulating the gut microbiota and increasing spermidine production, which enhances mitochondrial activity and provides kidney protection.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tohoku Univ. Technology：A Diagnostic Test Enabling Precision Oncology in Head and Neck Cancer：T25-030

Tohoku Univ. Technology：A Diagnostic Test Enabling Precision Oncology in Head and Neck Cancer：T25-030

Predicts Therapeutic Response to ICI and Anti-EGFR Antibody Treatments

For patients with platinum-sensitive recurrent or metastatic head and neck squamous cell carcinoma (HNSCC), first-line therapy usually involves pembrolizumab (an immune checkpoint inhibitor; ICI) with chemotherapy (5-FU plus cisplatin/carboplatin), or pembrolizumab alone for PD-L1–positive cases defined by the combined positive score (CPS). As a second-line option, cetuximab (anti-EGFR antibody) plus paclitaxel (CET+PTX) is commonly used. Our study revealed a mutually exclusive correlation between responses to first-line pembrolizumab and second-line CET+PTX. Comprehensive gene expression analyses identified key biomarkers linked to this correlation. This diagnostic approach allows prediction of each therapy’s efficacy in individual patients by measuring these biomarkers.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving>

Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving>

Caterpillar provides solutions, support, and specialized services for pharmaceutical challenges tailored to customer needs in various regions around the world.

Our sourcing specialist team leverages a global network of major manufacturers and key wholesalers to efficiently procure a variety of pharmaceuticals, even for items that are difficult to source, in the quantities you require. CatTalent delivers comparator drugs promptly to any location around the world through its global storage and distribution network for clinical trial drugs. Whether you only need procurement of comparator drugs or require comprehensive services such as over-encapsulation, blinding, packaging and labeling, storage and distribution, or regulatory consulting, we can customize procurement-related services to meet your needs.

  • Contract manufacturing
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Natural Proteoglycan, the Herbal Medicine of the Sea

Natural Proteoglycan, the Herbal Medicine of the Sea

Safe and secure materials! Ideal for use as ingredients in cosmetics and health foods.

"Natural Proteoglycan" is a safe and reliable material that can be taken orally. The raw material is salmon nasal cartilage, sourced entirely from salmon caught in Hokkaido. There are no concerns about BSE or foot-and-mouth disease, which are characteristic of mammals such as cows and pigs, nor is there any worry about avian influenza from birds. Additionally, we do not use farmed salmon that have been administered antibiotics. All reagents used in the extraction and purification processes are approved as food additives. 【Features】 ○ Safe and reliable material ○ Free from risk of side effects ○ High purity, tasteless and odorless ○ Non-heating manufacturing method ○ Free from additives For more details, please contact us or download the catalog.

  • Organic Natural Materials
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
K9 Lab Inc. Company Profile

K9 Lab Inc. Company Profile

We support veterinary medicine by providing animal genetic testing technology and lymphocyte culture techniques.

Our company supports veterinary medicine by providing advanced genetic testing technology to assist in the diagnosis of cancers and infectious diseases, offering lymphocyte culture techniques used in cancer immunotherapy, and developing new functional foods that can be shared between pet owners and their pets, ensuring companion animals receive appropriate examinations and treatments. Currently, we are accepting tests from animal hospitals nationwide. Furthermore, we are developing technology to apply activated lymphocyte culture techniques to the health management of livestock (with domestic and foreign patents obtained) and have begun the development of artificial red blood cells for animals, aiming for early practical application. 【Business Activities】 ■ Contracting, research, development, and technical guidance for animal clinical testing ■ Research, development, manufacturing, and sales of veterinary diagnostic drugs ■ Research, development, manufacturing, import, and sales of veterinary pharmaceuticals, reagents, and medical instruments and tools ■ Contracting and technical guidance for cell culture, preservation, and management ■ Research commissioning and technical guidance related to animal medicine ■ Other related services *For more details, please refer to the PDF materials or feel free to contact us.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Pharmatech Co., Ltd. "Company Profile"

Pharmatech Co., Ltd. "Company Profile"

Contract manufacturing of raw materials and intermediates is handled by Pharmatech Co., Ltd.

Pharmatech Co., Ltd. is a company located in Chuo Ward, Tokyo, engaged in the sales of pharmaceutical raw materials and intermediates. With a customer-oriented approach as our foundation, we aim to provide high-quality materials and services not only in Japan but also around the world. We consider it our significant mission to contribute to society through the sale of various raw materials related to pharmaceuticals, pharmaceutical intermediates, health foods, cosmetics, biochemical products, clinical testing reagents, industrial chemicals, and more. 【Business Activities】 ■ Export and sales of pharmaceutical raw materials ■ Sales of pharmaceutical intermediates, chemical products, toxic substances, reagents, and clinical testing reagents ■ Wholesale sales of pharmaceutical raw materials ■ Import and export, and domestic sales of food, food additives, and health foods ■ Sales of traditional Chinese medicine and plant extracts *For more details, please refer to our catalog. Feel free to contact us with any inquiries.

  • Chemicals
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Cavity prevention medicine Gurupepr

Cavity prevention medicine Gurupepr

From 4 years old to the elderly, let's all prevent cavities!

【Class 3 Pharmaceuticals】 (Over-the-Counter Medicines) Dispensing Pump Type 0.05% Sodium Fluoride Mouthwash "Cavity Prevention Medicine Gurupepr" - Prevents cavities with three major effects: acid resistance, remineralization, and acid production suppression. - Suitable for use from age 4 to the elderly. - Can be used for group rinsing at schools for 4 and 5-year-olds. - Effective for interproximal and root surface cavities in adults and the elderly. - Easy to dispense with a pump-type design. - Includes a memo section for noting the opening date and classroom name, etc. - Can be used at the original concentration without dilution. - Eligible for self-medication tax system. - Gargle once a day.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Indena Japan Co., Ltd. Introduction of Pharmaceutical Raw Materials

Indena Japan Co., Ltd. Introduction of Pharmaceutical Raw Materials

Pharmaceutical raw materials backed by CTD-DMF!

Our pharmaceutical raw materials are manufactured in facilities that have been inspected for pharmaceuticals in accordance with cGMP and are backed by CTD-DMF. Products created under excellent technology related to plant-derived ingredients include a wide range such as Ajmaline, Boldine, Colchicine USP, and Galantamine Hydrobromide. We will introduce them categorized as "isolated or semi-synthetic refined products" and "standardized, refined, or other characteristic dry extracts." 【Features】 ■ Backed by CTD-DMF ■ Manufactured in facilities that have been inspected for pharmaceuticals ■ Active ingredients derived from edible and medicinal plants *For more details, please refer to the catalog or feel free to contact us.

  • Pharmaceutical materials and carriers
  • Pharmaceutical Intermediates
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Ajuband "Synthetic Pristan"

Ajuband "Synthetic Pristan"

Monoclonal antibody production adjuvant using our unique manufacturing technology!

"Synthetic Pristan" is an adjuvant used in the production of monoclonal antibodies from mouse ascites. It is used to induce arthritis in mice for research on chronic rheumatoid arthritis. Our product offers high-performance items with minimal lot-to-lot variation. [Features] ■ Synthetic Pristan produced using our unique manufacturing technology ■ High-performance items with minimal lot-to-lot variation *For more details, please refer to the catalog or feel free to contact us.

  • Other research reagents
  • reagent
  • Research Antibodies
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
BioBridge Corporation Business Introduction

BioBridge Corporation Business Introduction

Due to our long-standing track record, we have been entrusted with numerous agency operations.

BioBridge Co., Ltd. has been expanding its transactions with high-quality pharmaceutical raw material manufacturers and contract laboratories, primarily in Europe and including Asia, since its establishment. We are also engaged in transactions with domestic pharmaceutical and chemical companies. We handle a wide range of products, from antibiotic raw material intermediates to generic active pharmaceutical ingredients, and radioactive isotopes (14C, 3H). 【Business Activities】 ■ Sales of pharmaceutical raw materials, radioactive isotopes, and chemicals ■ Liaison office and agency services for overseas pharmaceutical companies, testing and inspection organizations, and contract manufacturing companies ■ Application services for registration of pharmaceutical raw materials, among others *For more details, please download the PDF or feel free to contact us.

  • Pharmaceutical Intermediates
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
A new biotin labeling agent that allows control over the introduction location and quantity [Saitama University]

A new biotin labeling agent that allows control over the introduction location and quantity [Saitama University]

The key is the re-crosslinking of S-S bonds! A novel biotin labeling agent that stabilizes the structure and function of proteins.

Conventional biotin labeling randomly binds to the functional groups of proteins, making it difficult to control the number of biotins attached and their binding positions. Additionally, the cleaved S-S bonds for labeling do not re-bridge, leading to changes in the higher-order structure of the protein and a decrease in activity, which is a challenge. In this technology, biotin is introduced to the Br group of dibromo-pyridazine dione, and the re-bridging of S-S bonds occurs simultaneously with labeling. This stabilizes the higher-order structure of the protein and maintains its activity. The number of attached biotins can be selected as either one or two, and it can be used for controlling the orientation of proteins by utilizing the binding characteristics with streptavidin.

  • Chemicals
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Contract synthesis of small quantities of high-quality active pharmaceutical ingredients.

Contract synthesis of small quantities of high-quality active pharmaceutical ingredients.

Supports the manufacturing of investigational drug active ingredients and pharmaceutical active ingredients ranging from hundreds of grams to several kilograms!

At Kyu Chemical, we also handle the manufacturing of active pharmaceutical ingredients (APIs) for clinical trial drugs and pharmaceutical products on a gram scale. We conduct process improvements and data management with the premise of commercialization from the development stage, supporting everything from process development to market launch. Production activities are carried out under a management system compliant with ICH and PIC/S guidelines, and we are also capable of synthesizing compounds for drug discovery and related substances. If you have active pharmaceutical ingredients that are too small in quantity and have been rejected by overseas manufacturers, please contact us. 【Features】 ■ Manufacturing of highly pharmacologically active pharmaceutical ingredients (HPAPI) ■ Manufacturing of APIs for clinical trial drugs ■ Manufacturing of small quantities of APIs *For more details, please refer to the related links or feel free to contact us.

  • Other contract services
  • Other services
  • Chemicals
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
All-purpose test reagent

All-purpose test reagent

Measures from low range "LR" 0.02 to 2 mg/L and high range "HR" 0.2 to 30 mg/L.

We offer a total phosphorus test reagent based on the measurement principle of spectrophotometry (molybdenum blue method). The measurement ranges are low range "LR" 0.02 to 2 mg/L and high range "HR" 0.2 to 30 mg/L, with a processing time of 30 minutes at 125°C. *For more details, please download the PDF or contact us.

  • Testing Equipment and Devices
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Aptamer drug discovery technology "RiboART System"

Aptamer drug discovery technology "RiboART System"

We can develop various new drugs that are not limited to specific diseases or target proteins.

Our core drug discovery technology, the "RiboART (Ribomic Aptamer Refined Therapeutics) System," is built on comprehensive technologies, knowledge, and experience related to aptamer drug discovery, establishing a platform (drug discovery foundation) that can be universally applied to the creation of new drug candidates. By using the "RiboART System," it is possible to develop various new drugs that are not limited to specific diseases or target proteins. Please feel free to contact us if you have any inquiries. 【Features of Aptamer Pharmaceuticals】 ■ Strong target binding ability ■ Few restrictions on targets ■ Easy chemical modifications ■ Production through chemical synthesis ■ Low antigenicity *For more details, please download the PDF or contact us.

  • Other contract manufacturing
  • Technology Development
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Pharmaceutical Active Ingredient Division (Pharmaceutical Research Headquarters) Business and Technology

Pharmaceutical Active Ingredient Division (Pharmaceutical Research Headquarters) Business and Technology

Process optimization is possible! We propose a balanced active pharmaceutical ingredient development plan that considers speed, cost-effectiveness, and quality.

We would like to introduce our pharmaceutical active ingredient division (Pharmaceutical Research Headquarters) and its business and technology. We flexibly utilize a network of reliable partner contract manufacturers to build and propose an optimal active ingredient manufacturing supply chain tailored to specific purposes. With world-class pharmaceutical development technology and assured quality, we provide "the development of active ingredient manufacturing methods from 'zero' that meet global application requirements" and "a seamless and consistent active ingredient manufacturing process and quality design from preclinical stages to obtaining marketing approval." 【Features】 ■ Development of active ingredient manufacturing methods from 'zero' based on technology and know-how cultivated over many years at major domestic pharmaceutical companies. ■ Establishment of active ingredient manufacturing methods and quality design according to development stages and applications. ■ Flexible response to active ingredient manufacturing requests. ■ Accurate support for application processes (clinical trials and commercial use). *For more details, please refer to the PDF materials or feel free to contact us.

  • Other contract services
  • Technology Development
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Technology and Achievements Introduction] Absorption Improvement Technology (Nanosized Formulation)

[Technology and Achievements Introduction] Absorption Improvement Technology (Nanosized Formulation)

Introducing the correlation diagram of particle size and surface area! It is applied to investigational drugs targeting compounds in the development stage.

We would like to introduce Spela Pharma's "Absorption Improvement Technology." By using nano-sized active pharmaceutical ingredients, we enhance bioavailability. We have successfully developed formulations using this technology and are applying it to investigational drugs targeting compounds in the development stage. On our website, we provide a correlation chart of particle size and surface area, as well as graphs showing plasma concentration in dogs for nano-particles and jet-milled active pharmaceutical ingredients, so please check the related links below. [Features] ■ Improved bioavailability through nano-sized active pharmaceutical ingredients ■ Successful development of formulations using this technology ■ Application to investigational drugs targeting compounds in the development stage *For more details, please refer to the PDF materials or feel free to contact us.

  • Other contract services
  • Technology Development
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Thank You] CPhI Japan 2022

[Thank You] CPhI Japan 2022

Thank you for attending CPhI Japan 2022 (International Pharmaceutical Development Exhibition)!

Sperafarma exhibited at CPhI Japan 2022 (International Pharmaceutical Development Exhibition, April 20-22, Tokyo Big Sight) and welcomed many customers to our booth. As a CDMO capable of providing a wide range of services from early-stage R&D to the manufacturing of clinical trial drugs, commercial manufacturing, and raw material procurement, we will accelerate our support for pharmaceutical development. We would like to express our gratitude to everyone who provided us with opportunities for exchanging opinions and sharing information. 【Overview of Presentations at the Booth】 ■ Screening technologies required in active pharmaceutical ingredient research - catalyst selection, crystallization - ■ Mutagenic impurities in pharmaceuticals (active pharmaceutical ingredients) - development of testing methods and analysis examples - *For more details, please refer to the PDF materials or feel free to contact us.

  • Fine chemicals (compounds, derivatives, catalysts, etc.)
  • Other Testing Contract
  • Other analytical and testing equipment
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Drug discovery services

Drug discovery services

Next-generation antibody and peptide aptamer drug discovery business!

Our company is engaged in drug discovery business for next-generation antibodies and peptide aptamers through in-house research, joint research, and alliances. Under the NEDO Research and Development Venture Support Program (STS) for the fiscal year 2017, we successfully automated the "genotype/phenotype molecular matching technology," one of the evolving molecular engineering technologies, enabling the automated preparation of a homogeneous cDNA display library with a diversity of 10^14 (hundreds of trillions). In addition to the naive VHH gene library through a technical partnership with RePHAGEN, we also possess a high-quality peptide gene library in-house. *For more details, please contact us.

  • Other contract services
  • Other contract manufacturing
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Measures and initiatives for the 2024 problem: Logistics industry edition

Measures and initiatives for the 2024 problem: Logistics industry edition

The pressing issues in the transportation industry - the 2024 problem - efforts to address the labor shortage.

In the logistics industry, the following measures are being considered in response to the 2024 issue: 1. Improvement of working conditions Measures to improve drivers' working conditions include correcting long working hours, ensuring rest periods, and managing drivers' health. Additionally, the introduction of machinery that allows for easier handling of cargo, as well as parental leave and reduced working hours systems, are being promoted to create a work environment that is accessible to everyone, including women and the elderly, and to secure human resources. 2. Promotion of driver training and recruitment Providing attractive working styles for younger generations, women, and foreigners, as well as setting appropriate wages, are among the initiatives being considered. 3. Efficiency through IT implementation and utilization of autonomous driving technology As part of efficiency improvements through IT systems, the scheduling, reception, and calling of truck loading and unloading have been systematized to reduce waiting times. There are reports of initiatives such as using AI for optimal delivery planning and standardizing dispatch operations utilizing the cloud. With future advancements in autonomous driving technology, the realization of a driverless delivery system could potentially resolve the driver shortage. Flexible adaptability will be required.

  • Other core systems
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Antimicrobial Treatment

[Research Material] Global Market for Antimicrobial Treatment

Global Market for Antimicrobial Therapy: Penicillin, Cephalosporins, Quinolones, Aminoglycosides, Monobactams, Carbapenems, Macrolides, ...

This research report (Global Antibacterial Therapeutic Market) investigates and analyzes the current state of the global antibacterial therapeutic market and its outlook for the next five years. It includes information on the overview of the global antibacterial therapeutic market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the antibacterial therapeutic market include penicillin, cephalosporins, quinolones, aminoglycosides, monobactams, carbapenems, macrolides, and others, while the segments by application cover oral, topical, non-oral, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for antibacterial therapeutics. It also includes the market share of major companies in antibacterial therapeutics, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Hemophilia Treatment

[Market Report] Global Market for Hemophilia Treatment

World Market for Hemophilia Treatment: Advances in medical therapies that enhance patient quality of life in the management of this rare bleeding disorder.

The global hemophilia treatment market is making significant progress as advancements in medical therapies innovate the management of this rare bleeding disorder. Hemophilia is a condition caused by genetic factors that impairs the blood's ability to clot properly, leading to prolonged bleeding times and an increased risk of severe bleeding symptoms. However, the emergence of innovative treatments has allowed patients to experience improved outcomes and enhanced quality of life. According to the latest market report, the global hemophilia treatment market reached $12.8 billion in 2021, with a steady growth forecast of a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Enhancing molecular bonds to protect health!

Enhancing molecular bonds to protect health!

Keywords: glycan, antibody, molecular recognition, multivalent effect, detection reagent

The proverb "When three people gather, the wisdom of Monju" is often heard in our daily lives. Did you know that the power of groups exists even at the molecular level? Glycans facilitate intercellular communication by binding to glycan receptors, but individual glycans have only weak binding strength. However, when multiple glycans come together, their effect far exceeds simple addition, sometimes exhibiting astonishing powers that can be hundreds to hundreds of thousands of times greater. This is called the "multivalency effect." The characteristic of our research is to artificially replicate and further enhance this clever mechanism found in nature. We design artificial molecules that accumulate various molecules, such as glycans and next-generation antibodies, and investigate their interactions in detail. By effectively utilizing the power of molecular cooperation, we hope to contribute to the future of medicine.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【システム非公開】【指定医薬部外品】ヤクルトＢＬチュアブル整腸薬

【システム非公開】【指定医薬部外品】ヤクルトＢＬチュアブル整腸薬

水なしで、かんで服用できるストロベリー風味のチュアブルタイプの整腸薬です。

当社で運営する会員限定の卸売(仕入れ)サイト「Kenko卸.com」では、 「ヤクルトＢＬチュアブル整腸薬 126粒入」を取り扱っております。 ビフィズス菌・カゼイ菌を成人1日服用量（9錠中）に、合わせて約70億個配合しています。

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Fundamentals and Applications of Process Chemistry (Organic Synthesis) in Pharmaceutical Development

Fundamentals and Applications of Process Chemistry (Organic Synthesis) in Pharmaceutical Development

What should be considered to understand process chemistry and establish an effective manufacturing method compliant with GMP? Efforts in the lab? Scale-down.

Lecturer Representative Director of Pharmaceutical Research and Development Consulting, Mr. Mitsuki Hashimoto Target Audience: Individuals responsible for process chemistry in pharmaceutical development facing challenges Venue: Kawasaki City Educational and Cultural Center, Room 3 [Kanagawa, Kawasaki] 12 minutes on foot from JR Kawasaki Station, 10 minutes on foot from Keikyu Kawasaki Station Date and Time: April 27, 2011 (Wednesday) 10:30 AM - 4:00 PM [Individual Consultation: 4:00 PM - 4:30 PM (Reservation required)] Capacity: 30 people *Registration will close once full. Please apply early.

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
The tax accountant in Meguro Ward is Takumi Tax Accountant Office.

The tax accountant in Meguro Ward is Takumi Tax Accountant Office.

If you are in Meguro Ward, please consult Takumi Tax Accountant Office.

If you are looking for a tax accountant strong in manufacturing and construction industries, please consult Takumi Tax Accountant Office in Meguro Ward. We specialize in financial support from fundraising to achieving profitability.

  • Audit/Accounting
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.